- Дата: 25-10-2024, 17:00
Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients. Pharmacokinetics of fluconazole in pediatric patients. Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions. A randomized, double-blind comparability of itraconazole oral answer and fluconazole tablets within the remedy of esophageal candidiasis. A randomized double-blind research of caspofungin versus fluconazole for the treatment of esophageal candidiasis. A randomized, double-blind trial of anidulafungin versus fluconazole for the remedy of esophageal candidiasis. Resistance of Candida species to fluconazole. Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-contaminated kids: in vitro and clinical correlations. 281. Pons V, Greenspan D, Debruin M. Therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, prospective multicenter research of oral fluconazole versus clotrimazole troches. Caspofungin therapy of neonates with invasive candidiasis. Comparison of caspofungin and amphotericin B for invasive candidiasis. Comparison of fluconazole and nystatin oral suspensions for treatment of oral candidiasis in infants. A randomized, double-blind, parallel-group, dose-response research of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients. 278. Pienaar ED, Young T, Holmes H. Interventions for the prevention and management of oropharyngeal candidiasis related to HIV infection in adults and youngsters.